Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Alderson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cell Host & Microbe|February 16, 2011
T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonizationKristin L Moffitt, Todd M Gierahn, Ying-jie Lu, et al.
Vaccine|November 11, 2023
Vaccine value profile for Group B streptococcusCaroline L Trotter, Mark Alderson, Ziyaad Dangor, et al.
Plos One|May 14, 2025
Modeling protective meningococcal antibody responses and factors influencing antibody persistence following vaccination with MenAfriVac using machine learningMd Nasir, William B Weeks, Shahrzad Gholami, et al.
FEMS Immunology and Medical Microbiology|March 14, 2009
Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatisRhea N Coler, Ajay Bhatia, Jean-Francois Maisonneuve, et al.
Clinical and Vaccine Immunology : CVI|August 7, 2015
Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad ProtectionAusten Chen, Beth Mann, Geli Gao, et al.
The Journal of Infectious Diseases|September 18, 2013
Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion proteinBeth Mann, Justin Thornton, Richard Heath, et al.
Clinical and Vaccine Immunology : CVI|April 30, 2010
Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccineYing-Jie Lu, Puja Yadav, John D Clements, et al.
Vaccine|September 23, 2010
GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsisYing-Jie Lu, Luciana Leite, Viviane Maimoni Gonçalves, et al.
Vaccine|December 18, 2013
Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stabilityViviane M Gonçalves, Waldely O Dias, Ivana B Campos, et al.
Vaccine|April 13, 2019
Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infantsAderonke Odutola, Martin O C Ota, Martin Antonio, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cell Host & Microbe|February 16, 2011
T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonizationKristin L Moffitt, Todd M Gierahn, Ying-jie Lu, et al.
Vaccine|November 11, 2023
Vaccine value profile for Group B streptococcusCaroline L Trotter, Mark Alderson, Ziyaad Dangor, et al.
Plos One|May 14, 2025
Modeling protective meningococcal antibody responses and factors influencing antibody persistence following vaccination with MenAfriVac using machine learningMd Nasir, William B Weeks, Shahrzad Gholami, et al.
FEMS Immunology and Medical Microbiology|March 14, 2009
Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatisRhea N Coler, Ajay Bhatia, Jean-Francois Maisonneuve, et al.
Clinical and Vaccine Immunology : CVI|August 7, 2015
Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad ProtectionAusten Chen, Beth Mann, Geli Gao, et al.
The Journal of Infectious Diseases|September 18, 2013
Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion proteinBeth Mann, Justin Thornton, Richard Heath, et al.
Clinical and Vaccine Immunology : CVI|April 30, 2010
Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccineYing-Jie Lu, Puja Yadav, John D Clements, et al.
Vaccine|September 23, 2010
GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsisYing-Jie Lu, Luciana Leite, Viviane Maimoni Gonçalves, et al.
Vaccine|December 18, 2013
Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stabilityViviane M Gonçalves, Waldely O Dias, Ivana B Campos, et al.
Vaccine|April 13, 2019
Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infantsAderonke Odutola, Martin O C Ota, Martin Antonio, et al.
Pageof 2